JP2004509961A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2004509961A5 JP2004509961A5 JP2002531121A JP2002531121A JP2004509961A5 JP 2004509961 A5 JP2004509961 A5 JP 2004509961A5 JP 2002531121 A JP2002531121 A JP 2002531121A JP 2002531121 A JP2002531121 A JP 2002531121A JP 2004509961 A5 JP2004509961 A5 JP 2004509961A5
- Authority
- JP
- Japan
- Prior art keywords
- thiazolidine
- pyridyl
- ethoxy
- benzyl
- amino
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN805CH2000 | 2000-09-26 | ||
| PCT/US2001/029896 WO2002026737A1 (en) | 2000-09-26 | 2001-09-25 | Novel polymorphic forms of 5-[4-[2-[n-methyl-n-(2-pyridyl)amino]ethoxy]benzyl] thiazolidine-2,4-dione maleate and process for their preparation |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2004509961A JP2004509961A (ja) | 2004-04-02 |
| JP2004509961A5 true JP2004509961A5 (https=) | 2008-11-06 |
Family
ID=29266775
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2002531121A Pending JP2004509961A (ja) | 2000-09-26 | 2001-09-25 | ５−［４−［２−［ｎ−メチル−ｎ−（２−ピリジル）アミノ］エトキシ］ベンジル］チアゾリジン−２，４−ジオンマレイン酸塩の新規の多型形態およびそれらの調製方法 |
Country Status (15)
| Country | Link |
|---|---|
| EP (1) | EP1322647A1 (https=) |
| JP (1) | JP2004509961A (https=) |
| AU (1) | AU9123201A (https=) |
| BR (1) | BR0114196A (https=) |
| CA (1) | CA2426117A1 (https=) |
| CZ (1) | CZ2003864A3 (https=) |
| HU (1) | HUP0301161A3 (https=) |
| IL (1) | IL155036A0 (https=) |
| MX (1) | MXPA03002580A (https=) |
| NO (1) | NO324968B1 (https=) |
| NZ (1) | NZ525498A (https=) |
| PL (1) | PL360661A1 (https=) |
| SK (1) | SK3752003A3 (https=) |
| WO (1) | WO2002026737A1 (https=) |
| ZA (1) | ZA200303223B (https=) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6664278B2 (en) | 1997-12-16 | 2003-12-16 | Smithkline Beecham P.L.C. | Hydrate of 5-[4-[2-(N-methyl-N-(2-pyridil)amino)ethoxy]benzyl]thiazolidine-2,4-dione maleic acid salt |
| US20020137940A1 (en) | 1997-12-16 | 2002-09-26 | Smithkline Beecham P.L.C. | 5-[4-[2-(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2, 4-dione, maleic acid salt, hydrate as pharmaceutical |
| GB9726563D0 (en) | 1997-12-16 | 1998-02-11 | Smithkline Beecham Plc | Novel pharmaceutical |
| UA67844C2 (uk) | 1999-04-23 | 2004-07-15 | Смітклайн Бічам Плс | Поліморф 5-[4-[2-(n-метил-n-(2-піридил)аміно)етокси]бензил]тіазолідин-2,4-діону солі малеїнової кислоти |
| DE60004658T2 (de) | 1999-04-23 | 2004-06-24 | Smithkline Beecham Plc, Brentford | Thiazolidindionderivat und seine verwendung als antidiabetikum |
| US20040248945A1 (en) | 1999-04-23 | 2004-12-09 | Smithkline Beecham P.L.C. | Thiazolidinedione derivative and its use as antidiabetic |
| US7041691B1 (en) | 1999-06-30 | 2006-05-09 | Amgen Inc. | Compounds for the modulation of PPARγ activity |
| US20030171399A1 (en) | 2000-06-28 | 2003-09-11 | Tularik Inc. | Quinolinyl and benzothiazolyl modulators |
| WO2004062667A1 (en) * | 2003-01-08 | 2004-07-29 | Dr. Reddy's Laboratories Limited | Amorphous form of rosiglitazone maleate and process for preparation thereof |
| GB0307259D0 (en) * | 2003-03-28 | 2003-05-07 | Glaxo Group Ltd | Process |
| EP1468997A3 (en) * | 2003-04-18 | 2004-11-03 | CHEMI S.p.A. | Polymorphous forms of rosiglitazone maleate |
| GB2405403A (en) * | 2003-08-29 | 2005-03-02 | Cipla Ltd | Rosiglitazone maleate of particular polymorphic forms and methods of preparing rosiglitazone free base |
| UA83504C2 (en) | 2003-09-04 | 2008-07-25 | Селджин Корпорейшн | Polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione |
| US7223761B2 (en) | 2003-10-03 | 2007-05-29 | Amgen Inc. | Salts and polymorphs of a potent antidiabetic compound |
| AR047541A1 (es) * | 2004-02-13 | 2006-01-25 | Sandoz Ag | Fosfato de 5-[[4-[2-metil-2-piridinil-amino-etoxi]fenil]metil]-2,4 tiazolidinadiona (rosiglitazona) y sus formas polimorficas |
| EP1753759A2 (en) * | 2004-03-31 | 2007-02-21 | Sandoz AG | Novel co-precipitate of amorphous rosiglitazone |
| WO2005108396A1 (ja) * | 2004-05-11 | 2005-11-17 | Santen Pharmaceutical Co., Ltd. | 角結膜障害治療剤 |
| JP2005350451A (ja) * | 2004-05-11 | 2005-12-22 | Santen Pharmaceut Co Ltd | 角結膜障害治療剤 |
| CZ296472B6 (cs) * | 2004-07-27 | 2006-03-15 | Zentiva, A. S | Sul kyseliny stavelové s 5-[4-[2-(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidin-2,4-dionu azpusob její prípravy a její pouzití |
| ITMI20041537A1 (it) * | 2004-07-28 | 2004-10-28 | Chemi Spa | Nuova forma polimorfa del rosiglitazone maleato |
| CZ298424B6 (cs) * | 2005-05-24 | 2007-09-26 | Zentiva, A. S. | Zpusob krystalizace rosiglitazonu a jeho derivátuze smesných rozpouštedel |
| EP2184055A1 (en) | 2008-11-07 | 2010-05-12 | LEK Pharmaceuticals d.d. | Process for preparing solid dosage forms of rosiglitazone maleate |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SG59988A1 (en) * | 1987-09-04 | 1999-02-22 | Beecham Group Plc | Substituted thiazolidinedione derivatives |
| GB9218830D0 (en) * | 1992-09-05 | 1992-10-21 | Smithkline Beecham Plc | Novel compounds |
| EP0844997A1 (en) * | 1996-06-19 | 1998-06-03 | Dr. Reddy's Research Foundation | Novel polymorphic forms of troglitazone having enhanced anti-diabetic activity and a process for their preparation |
| CN1221417A (zh) * | 1996-07-26 | 1999-06-30 | 雷迪博士研究基金会 | 具有抗糖尿病、降低血脂、抗高血压性能的噻唑烷二酮化合物,其制备方法及其药物组合物 |
| GB9726566D0 (en) * | 1997-12-16 | 1998-02-11 | Smithkline Beecham Plc | Novel pharmaceutical |
| UA67844C2 (uk) * | 1999-04-23 | 2004-07-15 | Смітклайн Бічам Плс | Поліморф 5-[4-[2-(n-метил-n-(2-піридил)аміно)етокси]бензил]тіазолідин-2,4-діону солі малеїнової кислоти |
| DE60004658T2 (de) * | 1999-04-23 | 2004-06-24 | Smithkline Beecham Plc, Brentford | Thiazolidindionderivat und seine verwendung als antidiabetikum |
-
2001
- 2001-09-25 CZ CZ2003864A patent/CZ2003864A3/cs unknown
- 2001-09-25 NZ NZ525498A patent/NZ525498A/en unknown
- 2001-09-25 EP EP01971336A patent/EP1322647A1/en not_active Withdrawn
- 2001-09-25 BR BR0114196-1A patent/BR0114196A/pt not_active Application Discontinuation
- 2001-09-25 MX MXPA03002580A patent/MXPA03002580A/es active IP Right Grant
- 2001-09-25 AU AU9123201A patent/AU9123201A/xx active Pending
- 2001-09-25 IL IL15503601A patent/IL155036A0/xx unknown
- 2001-09-25 CA CA002426117A patent/CA2426117A1/en not_active Abandoned
- 2001-09-25 HU HU0301161A patent/HUP0301161A3/hu unknown
- 2001-09-25 JP JP2002531121A patent/JP2004509961A/ja active Pending
- 2001-09-25 WO PCT/US2001/029896 patent/WO2002026737A1/en not_active Ceased
- 2001-09-25 SK SK375-2003A patent/SK3752003A3/sk not_active Application Discontinuation
- 2001-09-25 PL PL01360661A patent/PL360661A1/xx not_active Application Discontinuation
-
2003
- 2003-03-25 NO NO20031356A patent/NO324968B1/no unknown
- 2003-04-24 ZA ZA200303223A patent/ZA200303223B/xx unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2004509961A5 (https=) | ||
| RU2001130883A (ru) | Новые полиморфные формы антидиабетического средства, способ их получения и содержащие их фармацевтические композиции | |
| TW201121544A (en) | Novel phenol derivative | |
| WO2000071540A1 (en) | Hydrochloride of fused-heterocycle compound | |
| JP2004509961A (ja) | ５−［４−［２−［ｎ−メチル−ｎ−（２−ピリジル）アミノ］エトキシ］ベンジル］チアゾリジン−２，４−ジオンマレイン酸塩の新規の多型形態およびそれらの調製方法 | |
| WO2008016175A1 (en) | Activator for peroxisome proliferator activated receptor | |
| JP2008539278A (ja) | 結晶性ロスバスタチンカルシウム | |
| US7598387B2 (en) | Synthesis of antidiabetic rosiglitazone derivatives | |
| JP2003531200A (ja) | 糖尿病、高脂血症、高コレステロール血症、およびアテローム性動脈硬化症の治療のための材料と方法 | |
| JP2004520393A5 (https=) | ||
| JP2005523300A5 (https=) | ||
| JP4634716B2 (ja) | ５−［４−［［３−メチル−４−オキソ−３，４−ジヒドロキナゾリン−２−イル］メトキシ］ベンジル］チアゾリジン−２，４−ジオンカリウム塩の新規な結晶形 | |
| WO2002028857A1 (en) | Polymorphs of pioglitazone hydrochloride and their use as antidiabetics | |
| RU2003112226A (ru) | Новые полиморфоные форы 5-[4-2-[n-метил-n-(2-пиридил)амино]этокси]тиазолидин-2,4-дион малеата и способ их получения | |
| KR20100098709A (ko) | 독사조신 메실레이트의 결정 다형(형태 ｉｖ) 및 이의 제조방법 | |
| KR20020022812A (ko) | 티아졸리딘디온 유도체를 함유하는 제약 조성물 및 그의제조 방법 | |
| RU2286345C2 (ru) | Полиморфные кристаллические формы 5-[4-2-[n-метил-n-(2-пиридил)амино]этокси]бензил]тиазолидин-2,4-дион малеата | |
| JP3884736B2 (ja) | ハロゲノベンジルアミノプロピオン酸誘導体 | |
| CN101395145A (zh) | 新的杂环的环烷基衍生物、制备其的方法和包含其的药物组合物 | |
| WO2015106674A1 (zh) | 一种安塞曲匹的晶型及其制备方法、其药物组合物和用途 | |
| EA051917B1 (ru) | Новая соль соединения-агониста рецептора гпп-1, способ ее получения и содержащая ее фармацевтическая композиция | |
| AU2002241506B2 (en) | Atorvastatin hemi-calcium form VII | |
| WO2003066612A1 (en) | Novel polymorphic forms of bicyclic antidiabetic agents: process for their preparation and pharmaceutical compositions containing them | |
| JPH083152A (ja) | アルキレンジアミン誘導体 | |
| HK1235776B (zh) | 唑苯衍生物的晶体 |